Commission decisions on applications for authorisation
The European Commission has granted four authorisations for two uses of the 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO) (review period expiry dates are in brackets) for:
- one use applied for by DIAGAST (4 January 2033); and
- one use applied for by Hospira Zagreb d.o.o. (4 January 2033).